In the first post on this new online service, Dr Ed Wild and Dr Jeff Carroll talk about the five new clinical trials enrolling now or starting soon for Huntington’s disease. Plus, a detailed discussion of the eagerly-awaited clinical trial of the first ‘huntingtin lowering’ drug to be tested in Huntington’s diease. Called HTT-Rx, the drug is an antisense oligonucleotide developed by Isis Pharmaceuticals Inc.